EUVIMEDEUVIMED entdecken
Crossref

Self‐Propelled Nanomotor for Cancer Precision Combination Therapy

Yijie Lu, Shikang Liu, Jiarong Liang, Zhiyi Wang, Yanglong Hou iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202304212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Yijie Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Spin-X Institute, School of Chemistry and Chemical Engineering, State Key Laboratory of Luminescent Materials and Devices, South China University of …. Hauptthemen laut MEDLINE: Doxorubicin, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China-German Collaboration Project, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of nanomotor provides an innovative concept for tumor treatment strategies. Conventional chemotherapeutic agents for tumors exit various therapeutic constraints due to the unique microenvironment of the tumor itself. Calcium overload, the aberrant accumulation of free calcium ions in the cytoplasm, is a well‐recognized contributor to damage and even cell death in numerous cell types. Such undesired destructive processes can be a novel means applicable to cancer ion interference therapy. Herein, the chemotherapeutic drug doxorubicin (DOX) and calcium peroxide as the driving force into nanomotors through a facile and understandable experimental scheme are successfully assembled. The modification of nucleic acid aptamer and NIR‐II fluorescent molecules on its surface simultaneously strengthens both the active targeting and imaging capability of tumor loci. Therefore, by a comprehensive assessment of nanomotors both in vitro and in vivo experiments, CaO 2 /DOX@HPS‐IR‐1061‐AS1411 demonstrates superior killing effects on tumor cells, and the intracellular reactive oxygen species produced by nanomotors is verified by molecular biology experiments to induce apoptosis of tumor cells and further achieve tumor therapeutic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinNeoplasmsHumansAnimalsCell Line, TumorMiceReactive Oxygen SpeciesPeroxidesApoptosisAptamers, NucleotideNanoparticlesAntineoplastic AgentsMice, NudeMice, Inbred BALB C

Stichwörter der Autor:innen

calcium overloadion interference therapynanomotorsreactive oxygen species

Substanzen

DoxorubicinReactive Oxygen Speciescalcium peroxidePeroxidesAptamers, NucleotideAntineoplastic Agents

Autor:innen und Institutionen

  • Spin-X Institute, School of Chemistry and Chemical Engineering, State Key Laboratory of Luminescent Materials and Devices, South China University of Technology, Guangzhou, 511442, China.
  • Beijing Key Laboratory for Magnetoelectric Materials and Devices, School of Materials Science and Engineering, Peking University, Beijing, 100871, China.
  • School of Materials, Sun Yat-Sen University, Shenzhen, 518107, China.

ORCID-Profile: Yanglong Hou

Förderung

  • National Natural Science Foundation of China
  • China-German Collaboration Project
  • National Key Research and Development Program of China
  • Guangzhou Basic and Applied Basic Research Foundation

Zitieren

APA

Lu, Y., Liu, S., Liang, J., Wang, Z., & Hou, Y. (2024). Self‐Propelled Nanomotor for Cancer Precision Combination Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304212

Vancouver

Lu Y, Liu S, Liang J, Wang Z, Hou Y. Self‐Propelled Nanomotor for Cancer Precision Combination Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304212

BibTeX
@article{Lu2024,
  author = {Lu, Yijie and Liu, Shikang and Liang, Jiarong and Wang, Zhiyi and Hou, Yanglong},
  title = {Self‐Propelled Nanomotor for Cancer Precision Combination Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202304212}
}
Kostenlos starten →